These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 15953276)

  • 1. Patients' management of migraine and chronic daily headache: a study of the members of the Migraine Action Association (United Kingdom).
    Peters M; Abu-Saad HH; Robbins I; Vydelingum V; Dowson A; Murphy M
    Headache; 2005 May; 45(5):571-81. PubMed ID: 15953276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migraine and chronic daily headache management: a qualitative study of patients' perceptions.
    Peters M; Abu-Saad HH; Vydelingum V; Dowson A; Murphy M
    Scand J Caring Sci; 2004 Sep; 18(3):294-303. PubMed ID: 15355524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The patients' perceptions of migraine and chronic daily headache: a qualitative study.
    Peters M; Huijer Abu-Saad H; Vydelingum V; Dowson A; Murphy M
    J Headache Pain; 2005 Feb; 6(1):40-7. PubMed ID: 16362190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
    Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
    Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
    Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of chronic daily headache in children and adolescents].
    Cuvellier JC
    Rev Neurol (Paris); 2009; 165(6-7):521-31. PubMed ID: 19041108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migraine treatment strategies: the global Migraine And Zolmitriptan Evaluation (MAZE) survey--phase IV.
    MacGregor EA; Brandes J; Gendolla A; Giammarco R
    Curr Med Res Opin; 2004 Nov; 20(11):1777-83. PubMed ID: 15537478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Headache diagnosis, management and morbidity in the Singapore primary care setting: findings from a general practice survey.
    Khu JV; Siow HC; Ho KH
    Singapore Med J; 2008 Oct; 49(10):774-9. PubMed ID: 18946609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the patients attending a specialist UK headache clinic over a 3-year period.
    Dowson AJ
    Headache; 2003 Jan; 43(1):14-8. PubMed ID: 12864753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A; Leonardi M; Bussone G; D'Amico D
    Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
    Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
    Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).
    De Diego EV; Lanteri-Minet M
    Cephalalgia; 2005 Mar; 25(3):184-90. PubMed ID: 15689193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of headache and migraine in Qatar.
    Bener A
    Neuroepidemiology; 2006; 27(2):61-6. PubMed ID: 16847389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of a negative response to topiramate therapy in patients with chronic migraine.
    Rothrock JF; Parada VA; Drinkard R; Zweifler RM; Key KF
    Headache; 2005; 45(7):932-5. PubMed ID: 15985112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topics in migraine management: a survey of headache specialists highlights some controversies.
    Evans RW; Lipton RB
    Neurol Clin; 2001 Feb; 19(1):1-21. PubMed ID: 11471758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic daily headache in adolescents: prevalence, impact, and medication overuse.
    Wang SJ; Fuh JL; Lu SR; Juang KD
    Neurology; 2006 Jan; 66(2):193-7. PubMed ID: 16434652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic daily headache in U.S. soldiers after concussion.
    Theeler BJ; Flynn FG; Erickson JC
    Headache; 2012 May; 52(5):732-8. PubMed ID: 22404747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
    Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
    Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update of Inpatient Treatment for Refractory Chronic Daily Headache.
    Lai TH; Wang SJ
    Curr Pain Headache Rep; 2016 Jan; 20(1):5. PubMed ID: 26707496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.